Carcinoma in situ of cervix uteri, exocervix

CD2_INSITU_CERVIX_UTERI_EXOCERVIX

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions None	293373
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D06.1& Cause of death: ICD-10 — D06.1& 2 out of 7 registries used, show all original rules.	259
4. Check minimum number of events None	259
5. Include endpoints None	259
6. Filter based on genotype QC (FinnGen only)	259

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D06
Name in latin: Carcinoma in situ exocervicis (uteri)

NAME	CD2_INSITU_CERVIX_UTERI_EXOCERVIX
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D061
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D061
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Carcinoma in situ of cervix uteri, exocervix based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Carcinoma in situ of cervix uteri, exocervix

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	259	259	-
Unadjusted period prevalence (%)	0.09	0.09	-
Median age at first event (years)	35.48	35.48	-

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
243: Matched controls
2429

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D06.1

ICD-10 Finland

Carcinoma in situ: Exocervix

+∞

323.0

243

8070/2-C53.9

ICD-O-3

Squamous cell carcinoma in situ, NOS, of cervix uteri

398.3

118.3

110

LDC03

NOMESCO Finland

Conisation of cervix uteri using diathermy or laser

31.8

101.1

144

106

ULA02

NOMESCO Finland

Kolposcopy

21.7

95.8

175

257

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

19.5

90.5

175

283

D06.0

ICD-10 Finland

Carcinoma in situ: Endocervix

215.7

64.5

N87.2

ICD-10 Finland

Severe cervical dysplasia, not elsewhere classified

20.3

49.7

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

10.4

49.0

111

181

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

6.4

35.3

116

302

8077/2-C53.9

ICD-O-3

Squamous intraepithelial neoplasia, high grade of cervix uteri

21.6

33.1

LDA10

NOMESCO Finland

Curettage of cervix uteri

10.2

32.5

ZXC00

NOMESCO Finland

Use of diathermy

50.8

29.6

N87.1

ICD-10 Finland

Moderate cervical dysplasia

13.1

23.5

8140/2-C53.9

ICD-O-3

Adenocarcinoma in situ, NOS, of cervix uteri

252.7

23.0

A63.0

ICD-10 Finland

Anogenital (venereal) warts

7.3

16.5

D06.9

ICD-10 Finland

Carcinoma in situ: Cervix, unspecified

159.1

14.6

LCD10

NOMESCO Finland

Vaginal hysterectomy

7.4

13.3

C53.02

ICD-10 Finland

Adenocarcinoma of the endocervix

57.3

9.7

N87.0

ICD-10 Finland

Mild cervical dysplasia

5.8

9.7

LEB00

NOMESCO Finland

Biopsy of vagina

11.3

9.4

8010/2-C53.9

ICD-O-3

Carcinoma in situ, NOS, of cervix uteri

+∞

9.4

G01AA10

ATC

clindamycin; vaginal

2.6

9.3

435

C539, 6666, 0

ICD-O-3

8.1

8.8

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.8

8.5

252

8140/3-C53.9

ICD-O-3

Adenocarcinoma, NOS, of cervix uteri

93.1

8.5

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

5.1

8.4

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

4.6

8.2

LDC00

NOMESCO Finland

Conisation of cervix uteri using knife

27.4

6.3

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

157

3.00

8.67

2.0

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

114

701

2.12

7.88

2.2

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

355

2.15

6.24

1.6

1.5

429.3

63580686.9

pmol/l

1.05

324

(3013512) EKG study

474

1.96

5.48

3.2

2.8

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

4.95

5.06

2.8

1.3

—

(40761536) Microorganisms panel - Urine sediment

171

2.07

3.38

2.3

3.1

—

(3021901) Oxygen saturation in Capillary blood

4.62

3.14

3.1

2.6

—

(3032080) INR in Blood by Coagulation assay

581

1.60

2.97

6.6

4.7

1.1

1.0

inr

0.05

200

(40768804) Tissue Pathology biopsy report

126

998

1.51

2.73

2.1

1.9

—

(3021440) Promyelocytes/100 leukocytes in Blood

163

1.95

2.71

2.9

4.5

0.3

0.1

—

(3019225) pH of Specimen

163

1.95

2.71

2.6

4.1

—

(36660697) Celiac disease serology panel - Serum

223

0.38

2.58

1.0

1.2

—

(3025159) Blasts/100 leukocytes in Blood

159

1.93

2.56

3.0

4.5

0.0

0.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

3.90

2.48

1.3

1.9

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

162

1.89

2.43

2.5

2.1

782.4

2896.0

u/l

—

(3041096) Erythrocytes [Presence] in Urine by Automated

638

1.49

2.31

3.1

2.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

594

1.50

2.29

3.9

4.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

212

1.75

2.28

3.5

31.4

33.1

0.37

155

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

640

1.49

2.27

2.2

2.8

21.9

20.7

ng/l

0.05

306

(3001019) Free T4 and TSH panel - Serum or Plasma

261

0.43

2.19

1.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

617

1.48

2.18

2.1

2.3

52.0

55.5

u/l

0.51

582

(3017181) Myelocytes/100 leukocytes in Blood

177

1.79

2.14

2.9

4.3

3.3

1.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

162

1.82

2.12

3.0

4.2

5.9

0.9

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

758

1.45

2.12

4.2

4.1

36.0

36.9

g/l

1.03

720

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

217

1.71

2.11

3.4

4.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

230

2127

1.73

2.06

3.5

3.3

1.3

1.2

mmol/l

0.91

213

2018

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

156

1.82

2.06

2.8

2.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

2.88

2.02

4.3

2.8

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

2.10

2.00

1.2

1.5

13.7

23.1

u/l

0.91

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

3.81

1.94

1.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

467

0.60

1.93

4.8

3.0

—

(40758558) Short blood count panel - Blood

552

0.63

1.83

7.5

6.9

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

2.63

1.82

4.0

2.3

—

(4035726)

165

1.71

1.73

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

2.85

1.66

1.4

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

235

2212

1.67

1.62

3.8

3.7

4.9

mmol/l

0.06

222

2119

(3009542) Hematocrit [Volume Fraction] of Blood

197

2123

0.70

1.61

7.9

11.3

39.2

39.7

0.28

144

1768

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

2.55

1.61

1.0

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

2.55

1.61

3.4

1.9

140.4

131.7

g/l

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

2.55

1.61

1.0

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

2.55

1.61

1.0

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

234

2201

1.65

1.61

3.8

3.7

1.5

1.6

mmol/l

0.32

221

2096

(3022217) INR in Platelet poor plasma by Coagulation assay

154

1.69

1.57

9.4

12.5

1.2

inr

0.03

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

127

0.38

1.54

1.2

1.5

—

(1616796) Gas panel - Central venous blood

2.64

1.52

7.0

1.7

—

(3025130) Human papilloma virus identified in Specimen

2.12

1.51

3.2

1.7

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

2.48

1.49

1.0

1.4

—

(3026008) Bacteria identified in Urine by Culture

548

1.38

1.45

2.4

2.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

183

1655

1.36

1.45

4.1

3.9

10.9

9.2

mm/h

0.74

168

1568

(3022806) Fractional oxyhemoglobin in Capillary blood

3.16

1.44

1.0

1.5

90.9

91.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

233

2201

1.58

1.42

10.3

3.9

mmol/l

0.10

225

2151

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

162

0.48

1.41

1.5

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

163

0.47

1.41

1.5

1.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

166

1486

1.33

1.37

3.3

3.7

—

(44813793)

2.98

1.36

1.4

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

0.00

1.35

0.0

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2.08

1.35

1.0

1.3

—

1.0

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

123

1060

1.31

1.32

3.3

3.8

6.0

6.3

mmol/l

0.82

114

968

(3009343) pH of Capillary blood

1.83

1.30

3.5

3.6

7.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

235

2233

1.57

1.28

3.9

4.0

2.9

mmol/l

0.20

222

2120

(3008037) Lactate [Moles/volume] in Venous blood

2.43

1.25

1.7

2.0

1.3

1.2

mmol/l

—

(3018010) Neutrophils/100 leukocytes in Blood

123

1066

1.29

1.25

5.5

5.6

55.2

56.8

0.97

117

1004

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

100

844

1.30

1.24

3.6

3.0

—

(3037522) Nuclear Ab [Titer] in Serum

389

1.39

1.23

1.3

1.4

1190.8

476.4

titre

0.91

(3016244) Insulin [Units/volume] in Serum or Plasma

2.66

1.22

4.6

3.3

32.2

15.3

mu/l

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

204

1895

1.36

1.22

4.9

4.4

14.2

14.3

pmol/l

0.08

192

1804

(3050129) First trimester maternal screen panel - Serum or Plasma

129

0.45

1.20

2.2

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

231

2195

1.48

1.17

10.3

10.2

139.7

mmol/l

0.02

223

2150

(3021960) Folate [Moles/volume] in Serum or Plasma

403

1.36

1.15

1.4

1.5

20.3

21.5

nmol/l

0.33

351

(4281824)

2.37

1.13

1.0

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

228

2164

1.45

1.13

5.4

5.1

1.8

2.3

mu/l

0.45

210

2065

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

178

1630

1.29

1.12

3.0

2.8

59.3

37.3

u/l

0.60

167

1568

(3021589) Normoblasts [#/volume] in Blood

113

979

1.27

1.12

10.5

7.9

0.0

e9/l

0.53

795

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

2.29

1.11

1.0

1.2

—

(3027315) Oxygen [Partial pressure] in Blood

2.29

1.11

4.9

2.0

8.5

9.4

kpa

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

2.29

1.11

1.0

1.2

—

(3013290) Carbon dioxide [Partial pressure] in Blood

2.29

1.11

4.9

2.0

5.1

5.0

kpa

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

2.29

1.11

1.0

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

535

0.72

1.11

1.4

2.0

2.1

g/l

0.07

340

(3025941) Bacteria identified in Stool by Culture

146

1.55

1.07

1.1

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

2.30

1.04

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

2.30

1.04

1.2

6.6

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

2.03

1.00

1.4

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

385

1.34

1.00

1.5

1.8

—

(3038515) Glucose [Moles/volume] in Venous blood

2.20

0.98

1.8

2.1

5.9

7.6

mmol/l

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.98

0.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

175

1.47

0.97

1.6

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.72

0.97

2.2

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

117

1.58

0.96

1.3

1.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

101

1.62

0.96

1.4

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

563

1.28

0.95

3.5

3.2

0.0

estimate

0.50

214

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.75

0.94

2.3

1.6

—

(3002030) Lymphocytes/100 leukocytes in Blood

121

1077

1.23

0.90

5.8

5.7

29.3

29.4

0.04

113

1010

(3048689) Calprotectin [Mass/mass] in Stool

328

1.33

0.89

2.5

2.2

195.0

87.7

ug/g

0.65

265

(21494755) Public health laboratory ask at order entry panel

352

0.71

0.88

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

361

0.72

0.85

1.3

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

199

0.63

0.82

1.3

1.5

—

(3019198) Lymphocytes [#/volume] in Blood

128

1156

1.21

0.80

5.9

5.6

1.9

2.0

e9/l

0.22

116

1043

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

1.5

—

441.8

—

(3044941) Cell count panel - Synovial fluid

0.00

0.79

0.0

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.79

0.0

1.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

105

931

1.21

0.79

2.3

75.4

74.8

nmol/l

0.07

874

(3009261) Glucose [Presence] in Urine by Test strip

120

1079

1.21

0.78

3.8

3.0

0.0

estimate

0.50

207

(3008898) HLA-B27 [Presence]

161

0.61

0.78

1.0

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1.78

0.77

8.2

3.1

27.5

46.6

u/ml

—

(3022145) Colonoscopy Study observation

253

0.69

0.76

1.7

1.2

—

(3012544) pH of Venous blood

116

1.50

0.76

1.5

3.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

132

0.59

0.76

1.1

1.7

—

(3000492) Spirometry study

212

1.36

0.74

1.4

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1.58

0.73

1.0

1.2

—

35.5

—

(3019069) Monocytes/100 leukocytes in Blood

116

1045

1.20

0.73

6.1

5.9

8.0

7.9

0.13

109

984

(3006504) Eosinophils/100 leukocytes in Blood

115

1037

1.20

0.71

5.9

5.6

2.8

2.7

0.05

107

970

(3009508) Creatinine [Moles/volume] in Urine

499

1.24

0.70

2.2

2.9

7.7

7.4

mmol/l

0.15

428

(3006315) Basophils [#/volume] in Blood

124

1129

1.19

0.68

6.0

5.6

0.0

e9/l

0.60

112

995

(40768793) Breast Pathology biopsy report

0.54

0.68

1.0

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

189

0.67

0.66

1.2

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1.80

0.66

1.0

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

129

1.42

0.65

1.1

1.3

—

1.1

—

(3003694) ABO and Rh group [Type] in Blood

641

0.82

0.62

1.5

—

(1002224) Polysomnography panel

137

0.64

0.62

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

117

1067

1.18

0.62

5.1

4.2

0.0

estimate

0.50

212

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

243

2370

1.41

0.62

10.4

8.8

23.0

24.0

u/l

0.66

235

2319

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.59

0.61

1.1

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.60

0.0

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.60

0.0

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

311

1.26

0.60

1.8

1.5

1.3

0.20

283

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

554

0.81

0.59

1.6

1.7

1.5

1.4

mmol/l

0.29

488

(3000850) Epithelial cells [#/volume] in Urine

358

1.24

0.59

2.0

2.2

6.8

9.6

e6/l

0.43

314

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

500

1.21

0.58

1.2

1.3

42.1

30.0

iu/ml

0.30

174

(3016650) Hepatitis A virus Ab [Presence] in Serum

1.64

0.56

1.2

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

445

1.21

0.56

3.2

3.8

1.6

6.1

mg/mmol

1.96

262

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

220

2125

1.23

0.55

4.1

3.7

5.6

mmol/l

0.51

208

2014

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

898

1.17

0.55

4.9

5.7

1.2

mmol/l

0.01

779

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

203

1948

1.19

0.53

4.8

4.4

37.1

38.0

mmol/mol

1.33

191

1854

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.55

0.53

1.2

—

(3000991) Gas panel - Venous blood

0.62

0.53

2.7

6.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

135

0.65

0.53

2.9

3.4

61.0

74.5

ng/l

—

130

(3001122) Ferritin [Mass/volume] in Serum or Plasma

127

1177

1.16

0.53

2.6

3.0

84.1

66.1

ug/l

1.20

117

1122

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

505

1.19

0.52

1.2

1.3

2.1

13.8

u/ml

3.61

220

(1761868) Lipid panel - Serum or Plasma

104

951

1.16

0.51

2.7

2.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

256

0.76

0.51

1.4

1.6

—

(3044640) Blood type and Crossmatch panel - Blood

631

1.17

0.51

1.8

2.0

—

(3023368) Bacteria identified in Blood by Culture

384

1.21

0.50

3.5

3.4

—

(3002582) Erythrocytes [#/volume] in Urine

517

1.18

0.50

2.3

2.6

274.8

76.9

e6/l

0.34

381

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

479

1.19

0.49

2.1

2.2

2.8

mg/l

0.03

413

(3015377) Calcium [Moles/volume] in Serum or Plasma

662

1.16

0.49

3.3

3.0

2.4

2.3

mmol/l

0.24

609

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

433

1.19

0.48

1.7

1.9

—

(3002032) Base excess in Venous blood by calculation

111

1.37

0.48

1.6

3.1

3.6

2.1

mmol/l

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

0.61

0.46

2.0

1.7

—

(3007461) Platelets [#/volume] in Blood

254

2508

1.66

0.46

17.4

16.0

270.3

269.1

e9/l

0.11

249

2468

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

304

1.21

0.45

1.4

1.6

—

(3042936) Bacteria identified in Isolate by Culture

251

0.78

0.45

1.5

1.9

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

465

1.18

0.44

1.9

2.0

—

(3016879) Cocaine [Presence] in Urine

104

1.37

0.44

1.5

1.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1.42

0.42

1.0

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.37

0.42

1.2

1.9

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.57

0.42

6.0

2.3

—

(3000330) Specific gravity of Urine by Test strip

1.45

0.42

5.5

2.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

462

0.84

0.42

1.4

1.6

—

(3011288) Drugs identified in Urine by Screen method

1.41

0.41

1.5

1.7

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.4

—

1.9

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.41

0.0

1.9

—

64.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

149

0.73

0.41

1.2

1.4

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

0.41

0.0

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.41

0.0

1.3

—

(3013115) Eosinophils [#/volume] in Blood

126

1183

1.13

0.40

6.1

0.2

e9/l

0.42

114

1065

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

192

0.77

0.39

1.3

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.44

0.39

1.2

1.5

—

(3012516) Albumin [Mass/volume] in Urine

423

1.17

0.39

2.3

3.2

8.0

381.4

mg/l

0.88

259

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.36

0.37

1.0

1.1

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

793

1.13

0.37

3.8

5.0

1.2

mmol/l

0.19

741

(3019309) Folate [Moles/volume] in Red Blood Cells

264

1.20

0.37

1.9

1.6

1384.2

1159.9

nmol/l

0.62

207

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.35

0.36

1.6

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.65

0.36

1.0

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.47

0.36

2.7

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

228

2231

1.18

0.34

11.2

10.5

18.2

18.0

mg/l

0.04

180

1681

(4010399)

127

1.28

0.34

1.3

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1.37

0.33

2.3

1.6

—

0.0

—

(40768443) Skin Pathology biopsy report

1.37

0.33

1.2

—

(3027008) Opiates [Presence] in Urine

110

1.29

0.32

1.5

1.4

—

(3001604) Monocytes [#/volume] in Blood

119

1125

1.11

0.32

6.2

5.6

0.5

e9/l

0.19

109

995

(3019832) Treponema pallidum Ab [Presence] in Serum

324

0.85

0.31

1.5

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.33

0.31

1.0

1.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

625

1.12

0.31

2.9

2.7

—

(3000764) Benzodiazepines [Presence] in Urine

111

1.28

0.30

1.5

1.4

—

(3028300) Cannabinoids [Presence] in Urine

111

1.28

0.30

1.5

1.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.35

0.30

4.5

4.4

25.8

25.2

mmol/l

—

(3028707) Methadone [Presence] in Urine by Screen method

1.23

0.29

1.7

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.33

0.28

1.1

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

483

1.12

0.28

1.5

2.3

309.1

4202.6

umol/l

1.80

441

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.24

0.27

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

309

0.86

0.27

1.3

2.0

—

(3019060) Gas panel - Arterial blood

0.70

0.26

3.2

5.9

—

(3030467) Casts [#/volume] in Urine by Automated count

468

1.11

0.24

2.2

2.4

0.4

0.3

e6/l

0.15

337

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

104

989

1.09

0.24

3.5

3.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

305

0.87

0.23

1.3

1.4

—

(3035350) Ketones [Presence] in Urine by Test strip

112

1070

1.08

0.23

3.7

3.0

0.0

estimate

0.00

209

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

107

1.23

0.22

2.9

2.3

36.4

38.7

u/l

0.22

100

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

169

1643

1.08

0.22

8.1

6.5

71.7

74.2

u/l

0.48

162

1551

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

716

1.09

0.21

1.7

1.8

93.2

98.3

pmol/l

0.52

394

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

0.21

0.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.21

0.0

2.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.21

0.0

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

0.21

0.0

1.4

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

74.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

8.8

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3012441) Differential panel - Pleural fluid

0.00

0.21

0.0

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

0.21

0.0

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

0.21

0.0

2.2

—

(3051611) Lipemic interference index of Serum or Plasma

0.00

0.21

0.0

2.7

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.21

0.0

4.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.00

0.21

0.0

3.1

—

17.3

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

0.00

0.21

0.0

2.7

—

12.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

0.21

0.0

1.6

—

(3028433) Virus identified in Specimen by Culture

0.00

0.21

0.0

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

155

0.83

0.20

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

0.20

0.0

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.18

0.19

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1.16

0.19

1.0

1.3

3.5

3.7

mmol/l

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

239

2363

1.15

0.19

12.8

11.2

67.2

66.5

umol/l

0.24

239

2363

(3022096) Basophils/100 leukocytes in Blood

105

1009

1.07

0.18

6.3

5.7

0.7

0.20

940

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.22

0.18

2.0

2.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1.11

0.17

4.0

2.9

7.7

9.7

mg/l

—

(3022313) Gas panel - Capillary blood

1.11

0.17

3.4

3.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

244

1.12

0.17

1.3

1.2

187.7

167.5

iu/ml

0.09

113

(3015736) pH of Urine

832

1.07

0.17

3.5

2.8

—

(3002256) Pathology report gross observation

293

1.11

0.16

1.2

—

(3027944) Amphetamines [Presence] in Urine

111

1.18

0.16

1.5

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

171

0.87

0.15

1.3

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.81

0.15

1.6

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

100

0.79

0.14

1.4

1.9

—

(3027945) Reticulocytes/100 erythrocytes in Blood

148

0.87

0.13

1.7

3.2

1.2

1.8

—

131

(3018418) pH of Serum or Plasma

547

0.94

0.12

4.1

3.7

7.4

0.01

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

250

0.91

0.11

2.4

2.6

4.3

e6/l

0.78

121

(3044290) Cell count panel - Cerebral spinal fluid

1.14

0.10

1.0

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.14

0.10

1.6

1.4

—

(40768797) Stomach Pathology biopsy report

291

1.07

0.10

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1.11

0.10

1.0

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.11

0.10

1.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.09

0.09

1.2

1.1

—

(3020891) Body temperature

1.07

0.09

2.8

4.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.09

0.09

1.3

1.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

539

1.05

0.09

1.9

2.0

136.6

102.6

u/l

0.28

522

(3034770) Mitochondria Ab [Titer] in Serum

0.79

0.08

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.79

0.08

1.2

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

0.76

0.08

1.2

1.1

—

56.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.84

0.07

1.0

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.84

0.07

1.0

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.83

0.07

1.0

1.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

0.82

0.07

3.7

7.2

95.1

94.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.81

0.07

1.0

1.1

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

0.81

0.07

3.7

7.1

0.9

0.7

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

0.81

0.07

3.3

7.0

2.0

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.05

0.07

1.3

1.2

—

(3019150) Specific gravity of Urine by Refractometry

468

0.95

0.07

3.4

3.1

1.0

kg/l

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

255

0.94

0.07

1.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

354

1.05

0.07

2.2

2.8

1240.1

543.0

ng/l

0.49

295

(3000494) Fungus identified in Specimen by Culture

244

0.94

0.06

1.6

1.3

—

(3018095) Leukocytes [#/volume] in Urine

683

1.03

0.06

2.8

3.1

77.1

38.5

e6/l

0.37

429

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

624

1.03

0.05

1.5

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.12

0.05

1.2

2.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

262

0.95

0.05

2.3

2.2

0.5

1.2

e6/l

2.03

134

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

184

1855

0.97

0.05

3.5

3.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

554

0.97

0.04

1.5

1.8

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

219

1.06

0.04

1.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

131

1295

1.02

0.04

10.7

8.9

3.9

e9/l

0.01

120

1134

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

608

1.03

0.03

1.2

1.3

0.6

2.0

u/ml

1.15

176

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

210

2110

0.97

0.02

11.0

8.8

88.6

89.6

ml/min/173m2

0.33

180

1714

(40761535) Cells panel - Urine sediment

142

1.06

0.02

3.5

3.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

222

1.04

0.02

2.0

1.4

—

(36304419) Bacteria [Presence] in Urine

483

1.02

0.01

2.0

2.3

—

(42870588) Differential panel, method unspecified - Blood

692

1.00

0.00

6.5

5.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

193

0.98

0.00

4.5

3.7

4.6

pmol/l

0.05

173

(40761511) CBC panel - Blood by Automated count

237

2374

0.98

0.00

11.1

9.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

304

0.99

0.00

2.7

3.0

18.7

159.1

ng/l

1.27

175

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

515

1.01

0.00

1.5

1.7

1.0

0.7

mg/l

0.40

391

(3044889) 12 lead EKG panel

145

1445

1.01

0.00

2.8

2.9

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

745

0.99

0.00

3.3

3.0

31.8

28.2

u/l

0.42

718

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

155

0.97

0.00

3.5

4.3

211.1

241.7

u/l

0.72

148

(3022621) pH of Urine by Test strip

125

1.04

0.00

3.0

2.0

—

(3001186) Copper [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

16.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.00

0.0

1.0

—

(3019174) dRVVT (LA screen)

0.00

0.0

1.0

—

(3024471) HLA-A [Type]

0.00

0.0

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.0

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.0

—

76.8

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.0

1.2

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

0.00

0.0

1.0

—

5.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

0.0

1.4

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

0.00

0.0

1.2

—

367.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3024263) Appearance of Synovial fluid

0.00

0.0

2.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

2.9

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

0.0

1.4

—

57.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.0

3.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

0.0

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.0

3.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

2.9

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.00

0.0

1.0

—

(37021550) Renin [Units/volume] in Plasma --upright

0.00

0.0

1.2

—

197.7

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

0.0

2.0

—

1.2

—

(3002619) Bacteria identified in Specimen by Culture

0.00

0.0

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.0

4.1

—

(3032057) Clostridioides difficile [Presence] in Stool

0.00

0.0

2.0

—

(3017704) Immunofixation for Urine

0.00

0.0

1.6

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

0.0

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

0.96

0.00

1.6

2.4

2.7

3.6

g/l

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.00

0.0

3.6

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

0.0

2.0

—

(3009871) Measles virus Ab [Titer] in Serum

0.00

0.0

1.8

—

(40768806) Pleura Pathology biopsy report

0.00

0.0

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.0

2.0

—

17.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1.02

0.00

2.2

2.6

153.3

163.8

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

0.00

0.0

1.8

—

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

0.0

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1.00

0.00

1.2

1.3

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

0.0

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

0.0

1.3

—

1915.0

—

(3045788) Cell count panel - Pleural fluid

0.00

0.0

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

0.94

0.00

2.7

1.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.00

0.0

2.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.00

0.0

1.0

—

(21494434) Karyotype in Bone marrow

0.00

0.0

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

0.00

0.0

2.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

0.00

0.0

2.8

—

(3051651) Icteric interference index of Serum or Plasma

0.00

0.0

2.5

—

(3011436) Histone Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.00

0.0

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.00

0.0

2.0

—

(3045414) Leukocytes [Presence] in Urine

0.92

0.00

1.6

1.5

—

(3011648) Oxygen content in Venous blood

0.00

0.0

2.1

—

13.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

0.96

0.00

1.4

1.0

—

0.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

0.95

0.00

1.6

1.7

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

0.0

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3034426) Prothrombin time (PT)

0.00

0.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_CERVIX_UTERI_EXOCERVIX – Carcinoma in situ of cervix uteri, exocervix

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Carcinoma in situ of cervix uteri, exocervix

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Carcinoma in situ of cervix uteri, exocervix (CD2_INSITU_CERVIX_UTERI_EXOCERVIX)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints